Al Mayadeen English

  • Ar
  • Es
  • x
Al Mayadeen English

Slogan

  • News
    • Politics
    • Economy
    • Sports
    • Arts&Culture
    • Health
    • Miscellaneous
    • Technology
    • Environment
  • Articles
    • Opinion
    • Analysis
    • Blog
    • Features
  • Videos
    • NewsFeed
    • Video Features
    • Explainers
    • TV
    • Digital Series
  • Infographs
  • In Pictures
  • • LIVE
News
  • Politics
  • Economy
  • Sports
  • Arts&Culture
  • Health
  • Miscellaneous
  • Technology
  • Environment
Articles
  • Opinion
  • Analysis
  • Blog
  • Features
Videos
  • NewsFeed
  • Video Features
  • Explainers
  • TV
  • Digital Series
Infographs
In Pictures
  • Africa
  • Asia
  • Asia-Pacific
  • Europe
  • Latin America
  • MENA
  • Palestine
  • US & Canada
BREAKING
Iran's judiciary: 935 people killed in Israeli strikes on Iran.
Al Mayadeen's correspondent: Knesset committee votes to advance impeachment of Arab MK Ayman Odeh.
TASS: Car explosion east of Moscow, ambulances rush to scene.
Al Mayadeen's correspondent: Over 10 martyrs and several wounded as Israeli forces opened fire on aid seekers on al-Tina Street, southwest of Khan Younis
A vehicle exploded in Washington, DC, the United States.
The Israeli occupation forces are carrying out extensive air raids on eastern and northeastern Gaza.
Israeli media: One Israeli soldier killed in a "security incident" in Khan Younis, south of the Gaza Strip
Israeli media: Intense exchange of fire in Khan Younis
Israeli media platform reports on a tough incident in Gaza still under media censorship
Iran's judiciary says 71 killed in Israeli strike on Evin Prison

Musk's Neuralink approved for in-human study

  • By Al Mayadeen English
  • Source: News Websites
  • 26 May 2023 12:19
2 Min Read

Musk has previously expressed much confidence in the implants - going so far as to say he would implant them in his own children.

  • x
  • Musk's Neuralink approved for in-human study
    Neuralink logo and Elon Musk are seen on December 19, 2022. (Reuters)

Elon Musk's brain-implant startup, Neuralink, announced on Thursday that it received clearance from the US Food and Drug Administration (FDA) to begin its first in-vivo clinical research, a vital step following previous setbacks.

Since 2019, Musk has forecast at least four times that Neuralink would begin human trials for a brain implant to cure serious ailments, including paralysis and blindness.

While it was established in 2016, it only sought FDA approval in early 2022 - and the government denied the application, according to seven current and former workers in March.

According to the workers, the FDA had raised various problems about Neuralink that needed to be rectified before human trials could be approved. The gadget's lithium battery, the potential of the implant's wires moving within the brain, and the difficulties of properly retrieving the device without injuring brain tissue were all major problems.

The FDA's clearance came as US legislators urge regulators to look into whether the composition of a panel monitoring animal testing at Neuralink led to botched and hurried trials.

Related News

Musk urges AI to replace public sector jobs, criticizes US government

Musk announces second successful Neuralink brain implant

Federal investigations were launched into Neuralink.

We are excited to share that we have received the FDA’s approval to launch our first-in-human clinical study!

This is the result of incredible work by the Neuralink team in close collaboration with the FDA and represents an important first step that will one day allow our…

— Neuralink (@neuralink) May 25, 2023

Last year, the USDA's inspector general began examining suspected breaches of the Animal Welfare Act, which controls how researchers care for and test certain types of animals, at the request of a federal prosecutor.

The investigation also looked at the USDA's monitoring of Neuralink.

Musk has been very ambitious about Neuralink in the previous years, stating last year that he had so much confidence in the device he would implant it in his own children. 

The Tesla CEO hopes to treat a variety of illnesses through the technology, including obesity, autism, depression, and schizophrenia, as well as enable online browsing and telepathy.

 

  • Elon Musk
  • Neuralink
  • Tesla

Most Read

Iranian President Masoud Pezeshkian attends a protest following the US attacks on nuclear sites in Iran, in Tehran, Iran, Sunday, June 22, 2025. (AP)

Iran declares victory as ceasefire forces Israeli retreat

  • Politics
  • 24 Jun 2025
Iran launches strikes on Israeli targets, despite alleged ceasefire

Iran victorious as ceasefire with 'Israel' takes effect

  • Politics
  • 24 Jun 2025
Iran says targeted US Qatar air base under Op. Annunciation of Victory

Iran says targeted US Qatar air base under Op. Annunciation of Victory

  • MENA
  • 23 Jun 2025
Gaza

7 Israeli soldiers killed in double ambush by Gaza Resistance

  • Palestine
  • 24 Jun 2025

Coverage

All
The Ummah's Martyrs

Read Next

All
Women comfort each other by a vehicle that was burnt overnight by Israeli settlers in an attack that killed three Palestinians and burnt several vehicles and damaged homes, in Kafr Malik, east of Ramallah, Thursday, June 26, 2025 (AP)
Politics

Settlers shoot and assault Palestinians in Hizma, Masafer Yatta

Syria's interim leader, Ahmad al-Sharaa, walks in the presidential palace ahead of a meeting in Damascus, Dec. 28, 2024. (AP)
Politics

Syria open to al-Sharaa-Netanyahu meeting at UN assembly

Former Iranian parliament speaker Ali Larijani speaks with media at the Interior Ministry in Tehran, Iran, Friday, May 31, 2024 (AP)
Politics

'Israel' failed to topple Iran, lost 12-day war, Larijani says

Smoke rises to the sky following an Israeli strike in the Gaza Strip as seen from southern Israel, Wednesday, June 11, 2025. (AP)
Politics

War on Gaza failed to achieve objectives in Gaza: Israeli media

Al Mayadeen English

Al Mayadeen is an Arab Independent Media Satellite Channel.

All Rights Reserved

  • x
  • Privacy Policy
  • About Us
  • Contact Us
  • Authors
Android
iOS